Mitoferrin modulates iron toxicity in a Drosophila model of Friedreich's ataxia
2015 (English)In: Free Radical Biology & Medicine, ISSN 0891-5849, E-ISSN 1873-4596, Vol. 85, 71-82 p.Article in journal (Refereed) Published
Friedreich's ataxia is the most important recessive ataxia in the Caucasian population. Loss of frataxin expression affects the production of iron sulfur clusters and, therefore, mitochondrial energy production. One of the pathological consequences is an increase of iron transport into the mitochondrial compartment leading to a toxic accumulation of reactive iron. However, the mechanism underlying this inappropriate mitochondrial iron accumulation is still unknown. Control and frataxin-deficient flies were fed with an iron diet in order to mimic an iron overload and used to assess various cellular as well as mitochondrial functions. We showed that frataxin-deficient flies were hypersensitive toward dietary iron and developed an iron dependent decay of mitochondrial functions. In the fly model exhibiting only partial frataxin loss, we demonstrated that the inability to activate ferritin translation and the enhancement of mitochondrial iron uptake via mitoferrin upregulation were likely the key molecular events behind the iron induced phenotype. Both defects were observed during the normal process of aging, confirming their importance in the progression of the pathology. In an effort to further assess the importance of these mechanisms, we carried out genetic interaction studies. We showed that mitoferrin downregulation improved many of the frataxin-deficient conditions, including nervous system degeneration, whereas mitoferrin overexpression exacerbated most of them. Taken together, this study demonstrates the crucial role of mitoferrin dysfunction in the etiology of Friedreich's ataxia and provides evidence that impairment of mitochondria! iron transport could be an effective treatment of the disease.
Place, publisher, year, edition, pages
2015. Vol. 85, 71-82 p.
Friedreich's ataxia, Frataxin, Drosophila melanogaster, Iron overload, Fer1HCH, Mitoferrin, Brain degeneration
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) Endocrinology and Diabetes
IdentifiersURN: urn:nbn:se:uu:diva-260606DOI: 10.1016/j.freeradbiomed.2015.03.014ISI: 000358198000007PubMedID: 25841783OAI: oai:DiVA.org:uu-260606DiVA: diva2:848328
FunderSwedish Research Council
Funding: Elitenetzwerk Bayern2015-08-242015-08-212015-08-24Bibliographically approved